Novo nordisk terminates collaboration with hims & hers health, inc. due to concerns about their illegal mass compounding and deceptive marketing

Collaboration of over one month has ended based on hims & hers deceptive promotion and selling of illegitimate, knockoff versions of wegovy ® that put patient safety at risk novo nordisk won't stop taking action to protect americans from the dangers of illicit foreign active pharmaceutical ingredients in knock-off drugs efforts will continue to make authentic, fda-approved wegovy® directly available through novocare ® pharmacy to select telehealth organizations that share our commitment to safe and effective medical treatment for patients living with chronic diseases plainsboro, n.j. , june 23, 2025 /prnewswire/ -- novo nordisk announced today that the company will no longer be working with hims & hers health, inc., and that direct access to wegovy® will no longer be available to hims & hers health, inc. via novocare® pharmacy.
HIMS Ratings Summary
HIMS Quant Ranking